C-U
    
      
        
          0001868109
          XXXXXXXX
        
        020-30193
      
      LIVE
      
        false
        false
        false
      
    
  
  
    
      The Offering closed successfully on 8/8/2022, having received investment commitments of $68,204.00, although a final accounting has not taken place.
      
        BioLight, Inc.
        
          Corporation
          DE
          06-10-2021
        
        
          3943 STEVENSVILLE RIVER RD
          APT B
          STEVENSVILLE
          MT
          59870
        
        https://www.biolight.shop
      
      N
      OpenDeal Portal LLC
      0001751525
      007-00167
      283874
    
    
      At the conclusion of the offering, the issuer shall pay a fee of six percent (6%) of the amount raised in the offering to the Intermediary.
      The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the offering.
      Other
      Crowd SAFE (Simple Agreement for Future Equity)
      25000
      1.00000
      Arbitrary
      25000.00
      Y
      Other
      At the Intermediary's discretion
      1000000.00
      09-26-2022
    
    
      0.00
      25000.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      25000.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      0.00
      -5621.00
      0.00
      AL
      AK
      AZ
      AR
      CA
      CO
      CT
      DE
      DC
      FL
      GA
      HI
      ID
      IL
      IN
      IA
      KS
      KY
      LA
      ME
      MD
      MA
      MI
      MN
      MS
      MO
      MT
      NE
      NV
      NH
      NJ
      NM
      NY
      NC
      ND
      OH
      OK
      OR
      PA
      PR
      RI
      SC
      SD
      TN
      TX
      UT
      VT
      VA
      WA
      WV
      WI
      WY
    
    
      
        BioLight, Inc.
        Michael Belkowski
        Chief Executive Officer
      
      
        
          Michael Belkowski
          Director
          08-08-2022